GSK3858279
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for GSK3858279, covering 2023-08-01 to 2025-11-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain [Phase 2]